What is Phoenix S&T?
Phoenix S&T operates at the intersection of high-performance liquid chromatography and mass spectrometry, providing critical hardware solutions that enhance the efficacy of nanoLC-MS and microLC-MS systems. Their product portfolio, which includes precision column heaters, advanced cooling systems, and specialized spray emitters, is engineered to meet the rigorous demands of modern laboratory environments. By prioritizing customer-driven innovation, Phoenix S&T has established itself as a reliable partner for researchers and industrial chemists who require high-fidelity data and consistent performance in their analytical workflows. The company's commitment to technical excellence and responsive service has allowed it to maintain a competitive edge in a niche yet essential segment of the life sciences supply chain.
How much funding has Phoenix S&T raised?
Phoenix S&T has raised a total of $28K across 1 funding round:
Debt
$28K
Debt (2021): $28K with participation from PPP
Key Investors in Phoenix S&T
PPP
Public-Private Partnership
What's next for Phoenix S&T?
With the recent infusion of capital, Phoenix S&T is poised to accelerate its product development roadmap and expand its international market reach. The strategic focus will likely shift toward enhancing manufacturing capabilities to meet the rising demand for high-throughput analytical tools. As the company transitions through its current growth phase, the emphasis will remain on scaling its core technology while exploring new applications for its hardware in emerging biotech fields. Investors and industry stakeholders will be monitoring how the firm utilizes this liquidity to optimize its supply chain and deepen its penetration into key global research hubs, ensuring long-term sustainability and market leadership in the analytical instrumentation space.
See full Phoenix S&T company page
